China Pharma Holdings (CPHI) Inventory Average (2011 - 2026)

China Pharma Holdings (CPHI) has reported Inventory Average for 16 consecutive years, with $2.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory Average fell 5.66% year-over-year to $2.6 million; the trailing twelve-month figure through Jun 2026 stood at $2.6 million (down 5.66% YoY), and the FY2025 full-year result was $2.8 million, down 16.34% from the prior year.
• Inventory Average eased to $2.6 million in Q2 2026 per CPHI's latest filing, from $2.7 million in the prior quarter.
• Across five years, Inventory Average topped out at $3.8 million in Q3 2023 and bottomed at $2.6 million in Q2 2026.
• Historically, Inventory Average has averaged $3.2 million across 5 years, with a median of $3.1 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Inventory Average jumped 30.75% in 2023, then sank 30.76% in 2024.
• Over 5 years, Inventory Average stood at $2.9 million in 2022, then soared by 30.75% to $3.8 million in 2023, then slumped by 30.02% to $2.7 million in 2024, then advanced by 3.17% to $2.8 million in 2025, then fell by 6.71% to $2.6 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $2.6 million, $2.7 million, and $2.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.